Maternal use of fertility drugs and risk of cancer in children - A nationwide population-based cohort study in Denmark

International Journal of Cancer

Volumn 136, Issue 8, 2015, Pages 1931-1939

  Hargreave, Marie ^a   Jensen, Allan ^a   Nielsen, Thor Schütt Svane ^a   Colov, Emilie Palmgren ^a   Andersen, Klaus Kaae ^a   Pinborg, Anja ^b   Kjaer, Susanne Krüger ^a,c  

^a DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Assisted reproduction technology; Childhood cancer; Fertility treatment; Infertility; Progesterone

Indexed keywords

CHORIONIC GONADOTROPIN; CLOMIFENE; FERTILITY PROMOTING AGENT; GONADORELIN DERIVATIVE; GONADOTROPIN; PROGESTERONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; DENMARK; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; DRUG USE; FEMALE; FEMALE INFERTILITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; YOUNG ADULT; ADOLESCENT; CASE CONTROL STUDY; INCIDENCE; INFANT; NEOPLASMS; NEWBORN; PRESCHOOL CHILD; RISK; SIBLING;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; DENMARK; FEMALE; FERTILITY AGENTS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; NEOPLASMS; PROGESTERONE; RISK; RISK FACTORS; SIBLINGS; YOUNG ADULT;

EID: 84922553477     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29235     Document Type: Article

References (45)

1. Pritchard-Jones K, Kaatsch P, Steliarova-Foucher E, et al. Cancer in children and adolescents in Europe: developments over 20 years and future challenges. Eur J Cancer 2006;42:2183-90.
2. Kaatsch P. Epidemiology of childhood cancer. Cancer Treat Rev 2010;36:277-85.
3. Terracini B. Epidemiology of childhood cancer. Environ Health 2011;10(Suppl 1):S8.
4. Steliarova-Foucher E, Stiller C, Kaatsch P, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004;364:2097-105.
5. Lightfoot TJ, Roman E. Causes of childhood leukaemia and lymphoma. Toxicol Appl Pharmacol 2004;199:104-17.
6. Michalek AM, Buck GM, Nasca PC, et al. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol 1996;143:996-1001.
7. Ferraretti AP, Goossens V, Kupka M, et al. Assisted reproductive technology in Europe, 2009: results generated from European registers by ESHRE. Hum Reprod 2013;28:2318-31.
8. Danish Fertility Society. Available at: http://www.fertilitetsselskab.dk/images/2014-dok/2013-resultater/dfs2013.pdf; accessed April 1, 2014.
9. Vlahos NF, Economopoulos KP, Creatsas G. Fertility drugs and ovarian cancer risk: a critical review of the literature. Ann NY Acad Sci 2010;1205:214-9.
10. Wysowski DK. Use of fertility drugs in the United States, 1973 through 1991. Fertil Steril 1993;60:1096-8.
11. Mosgaard B, Lidegaard O, Andersen AN. Use of fertility drugs in Denmark 1973-1993. An analysis based on sale statistics. Acta Obstet Gynecol Scand 1995;74:614-8.
12. Cohen SM, Ellwein LB. Cell proliferation in carcinogenesis. Science 1990;249:1007-11.
13. Herbst AL, Ulfelder H, Poskanzer DC, et al. Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. Am J Obstet Gynecol 1999;181:1574-5.
14. Kallen B, Finnstrom O, Lindam A, et al. Cancer risk in children and young adults conceived by in vitro fertilization. Pediatrics 2010;126:270-6.
15. Marees T, Dommering CJ, Imhof SM, et al. Incidence of retinoblastoma in Dutch children conceived by IVF: an expanded study. Hum Reprod 2009;24:3220-4.
16. Schuz J, Kaatsch P, Kaletsch U, et al. Association of childhood cancer with factors related to pregnancy and birth. Int J Epidemiol 1999;28:631-9.
17. Rudant J, Amigou A, Orsi L, et al. Fertility treatments, congenital malformations, fetal loss, and childhood acute leukemia: the ESCALE study (SFCE). Pediatr Blood Cancer 2013;60:301-8.
18. Petridou ET, Sergentanis TN, Panagopoulou P, et al. In vitro fertilization and risk of childhood leukemia in Greece and Sweden. Pediatr Blood Cancer 2012;58:930-6.
19. Williams CL, Bunch KJ, Stiller CA, et al. Cancer risk among children born after assisted conception. N Engl J Med 2013;369:1819-27.
20. McLaughlin CC, Baptiste MS, Schymura MJ, et al. Maternal and infant birth characteristics and hepatoblastoma. Am J Epidemiol 2006;163:818-28.
21. Brinton LA, Kruger KS, Thomsen BL, et al. Childhood tumor risk after treatment with ovulation-stimulating drugs. Fertil Steril 2004;81:1083-91.
22. Klip H, Burger CW, De KJ, et al. Risk of cancer in the offspring of women who underwent ovarian stimulation for IVF. Hum Reprod 2001;16:2451-8.
23. Bruinsma F, Venn A, Lancaster P, et al. Incidence of cancer in children born after in-vitro fertilization. Hum Reprod 2000;15:604-7.
24. Doyle P, Bunch KJ, Beral V, et al. Cancer incidence in children conceived with assisted reproduction technology. Lancet 1998;352:452-3.
25. Puumala SE, Spector LG, Wall MM, et al. Infant leukemia and parental infertility or its treatment: a Children's Oncology Group report. Hum Reprod 2010;25:1561-8.
26. Puumala SE, Ross JA, Wall MM, et al. Pediatric germ cell tumors and parental infertility and infertility treatment: a Children's Oncology Group report. Cancer Epidemiol 2011;35:e25-e31.
27. Puumala SE, Ross JA, Olshan AF, et al. Reproductive history, infertility treatment, and the risk of acute leukemia in children with down syndrome: a report from the Children's Oncology Group. Cancer 2007;110:2067-74.
28. Puumala SE, Ross JA, Feusner JH, et al. Parental infertility, infertility treatment and hepatoblastoma: a report from the Children's Oncology Group. Hum Reprod 2012;27:1649-56.
29. Mallol-Mesnard N, Menegaux F, Lacour B, et al. Birth characteristics and childhood malignant central nervous sytem tumors: the ESCALE study (French Society for Childhood Cancer). Cancer Detect Prev 2008;32:79-86.
30. Olshan AF, Smith J, Cook MN, et al. Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. Am J Epidemiol 1999;150:930-8.
31. Roman E, Ansell P, Bull D. Leukaemia and non-Hodgkin's lymphoma in children and young adults: are prenatal and neonatal factors important determinants of disease? Br J Cancer 1997;76:406-15.
32. Foix-L'Helias L, Aerts I, Marchand L, et al. Are children born after infertility treatment at increased risk of retinoblastoma? Hum Reprod 2012;27:2186-92.
33. Hargreave M, Jensen A, Toender A, et al. Fertility treatment and childhood cancer risk: a systematic meta-analysis. Fertil Steril 2013;100:150-61.
34. Hargreave M, Jensen A, Deltour I, et al. Increased risk for cancer among offspring of women with fertility problems. Int J Cancer 2013;133:1180-6.
35. Storm HH, Michelsen EV, Clemmensen IH, et al. The Danish Cancer Registry-history, content, quality and use. Dan Med Bull 1997;44:535-9.
36. Birch JM, Marsden HB. A classification scheme for childhood cancer. Int J Cancer 1987;40:620-4.
37. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
38. Jensen A, Sharif H, Frederiksen K, et al. Use of fertility drugs and risk of ovarian cancer: Danish Population Based Cohort Study. BMJ 2009;338:b249.
39. Van Steensel-Moll HA, Valkenburg HA, Vandenbroucke JP, et al. Are maternal fertility problems related to childhood leukaemia? Int J Epidemiol 1985;14:555-9.
40. Kramer S, Ward E, Meadows AT, et al. Medical and drug risk factors associated with neuroblastoma: a case-control study. J Natl Cancer Inst 1987;78:797-804.
41. Mandel M, Toren A, Rechavi G, et al. Hormonal treatment in pregnancy: a possible risk factor for neuroblastoma. Med Pediatr Oncol 1994;23:133-5.
42. Ellis L, Atadja PW, Johnstone RW. Epigenetics in cancer: targeting chromatin modifications. Mol Cancer Ther 2009;8:1409-20.
43. Franks LM, Teich NM. Introduction to the cellular and molecular biology of cancer, 3rd edn. Oxford; New York: Oxford University Press, 1997. 282.
44. National Toxicology Program. 12th Report on Carcinogens. Research Triangle Park, NC: National Institute of Enviromental Health Sciences. Available at: http://ntp. niehs.nih.gov/ntp/roc/twelfth/profiles/Progesterone.pdf; accessed August 1, 2013.
45. Senderovitz T, Christensen HR. Lægemidler i graviditeten II. Praktisk Lægemiddelinformation 1999;16:3-4.